Table 2.

Prevalence of anemia and deficiency of iron and RBC folate in non-pregnant women, aged 15–49 years, Jordan 2002 and 2010.

Indicator	2002		2010		P-valued
	n	% (95% CI)	n	% (95% CI)
Anemiaa	1023	29.3 (26.3, 32.6)	2030	29.2 (26.8, 31.7)	0.96
IDb	1021	38.7 (34.6, 42.9)	2035	35.1 (32.2, 38.1)	0.17
IDAc	1021	20.0 (17.3, 22.9)	2026	19.1 (17.3, 21.2)	0.61
RBC folate (deficiency)e		NA	393	13.6 (10.2, 17.8)
RBC folate (insufficiency)f		NA	393	82.9 (77.7, 87.1)

Abbreviations: CI, confidence interval; ID, iron deficiency; IDA, iron deficiency anemia; NA, not applicable; RBC, red blood cell. Note: the n’s are unweighted denominators for each subgroup. Percentages are weighted. CI, adjusted for cluster sampling design.

^aAnemia, defined as hemoglobin (Hb) <120 g/l, not adjusted for altitude.

^bID defined as serum ferritin <15ng/ml.

^cIDA defined as low Hb (<120 g/l) with low serum ferritin (<15 ng/ml).

^d2002 and 2010 percentages for each indicator compared using the Wald statistic for the difference between prevalence estimates in 2002 and 2010.

^eRBC folate deficiency defined as <151 ng/ml.

^fRBC folate insufficiency defined as ≤400 ng/ml.